Annexon, Inc. — Form D

Annexon, Inc. of Brisbane, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-22. The offering totals $130.5M, of which $130.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
William H Carson, M.D.DirectorBrisbane, CA
Jung E ChoiDirectorBrisbane, CA
Bettina M Cockroft, M.D.DirectorBrisbane, CA
Douglas LoveDirectorBrisbane, CA
Muneer A SatterDirectorChicago, IL
William D WaddillDirectorBrisbane, CA
Thomas G WiggansDirectorBrisbane, CA
Jennifer LewExecutive OfficerBrisbane, CA
Douglas LoveExecutive OfficerBrisbane, CA
Larry C Mattheakis, Ph.DExecutive OfficerBrisbane, CA
Michael C OverdorfExecutive OfficerBrisbane, CA
William D YoungDirectorLondon, X0
Stacie WeningerDirectorWatertown, MA
Ted YednockExecutive OfficerSouth San Francisco, CA
Emmett E CunninghamDirectorSouth San Francisco, CA
Carol E GallagherDirectorSouth San Francisco, CA
Campbell E MurrayDirectorSouth San Francisco, CA
Sanjay KeswaniExecutive OfficerSouth San Francisco, CA
Ricky A SunDirectorSouth San Francisco, CA
Campbell L MurrayDirectorSo. San Francisco, CA
Thomas L WiggansDirectorSo. San Francisco, CA
Emmett L CunninghamDirectorSo. San Francisco, CA
Ricky L SunDirectorSo. San Francisco, CA
Muneer L SatterDirectorSo. San Francisco, CA
Carol L GallagherDirectorSo. San Francisco, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2020-07-16D$102.0M$102.0M
2018-12-19D$85.0M$45.0M
2011-08-22D$1000K$1000K

More